Art Sullivan, a 38-year-old Ironman athlete, and Josh Lehman, 48, who works at the University of Rochester, are connected by an unlikely foe: a type of brain tumor called an astrocytoma that tends to afflict younger adults. They are also benefiting from the first new treatment for this cancer in decades—and it’s changing their lives.
This article was originally published on MedicalXpress.com